Global Peripheral Blood Mononuclear Cells Market was valued at USD216.52 Million in 2021 and is further anticipated to grow at a CAGR of 9.38%, during the forecast period owing to rise in number of cell therapies. The expansion in research & development schemes being initiated by various governments, and private institutions across the globe is further expected to create lucrative opportunities for the growth of the market.

Furthermore, increased focus of key players on R&D in peripheral blood mononuclear cells, as well as an increase in demand for cell operations among the population, are projected to provide market players with lucrative prospects in the future.

Growing Rate of Toxicology Research

Customer’s growing desire for Peripheral Blood Mononuclear Cells, as well as a growing preference for antibody development, are two important growth drivers for the growth of the market. The study on PBMC cells is mandatory to understand the biology and pathology related pathways as well as in clinical research, research on life threatening diseases, immunology, vaccine development, etc. PBMCs provide information on effects of prospective novel medication molecules on people, particularly on their immune systems. Drug toxicity that affects PBMCs can result in several serious, sometimes fatal toxic side effects, including immune system suppression and poisoning.

Increasing Usage of Peripheral Blood Mononuclear Cells for Cell Therapy

Patients now have a better alternative to cell-based therapies with respect to traditional regenerative medicines, but their side effects can hindered its use among customers. In this product category, developed regions such as North America and Europe have a strong presence of cell therapies for human well-being. Population is gaining awareness regarding the use of peripheral blood mononuclear cells in cell and gene therapy. Hence, the extraction and usage of peripheral blood mononuclear cells prove to be the key driving force for the market growth. However, the fatal diseases such as acute myocardial infarction, chronic heart failure, spinal cord injury, stroke, and wound healing have all been successfully treated in pre-clinical studies using the secretome of apoptotic peripheral blood mononuclear cells which drives the market growth, globally.

Growth in R&D of Peripheral Blood Mononuclear Cells for Human Well-Being

Rapid advancements in research and development (R&D) practices and activities are propelling the growth of the market as novel cell/gene therapies/medications and new products are developed for the treatment of fatal diseases. PBMCs are a reasonably straightforward way to acquire physiologically relevant (immune) proteins from routinely collected blood samples, and they do so without the native human plasma's well-known analytical challenges brought on by the presence of highly abundant proteins for driving the growth of the market. Furthermore, government of different countries are also providing funds for the ongoing research of peripheral blood mononuclear cells.

 

Download Free Sample Report

Market Segmentation

The Global Peripheral Blood Mononuclear Cells Market is segmented based on product, application, technique, source, and region. Based on Product, the market can be split into Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC. Based on Application, the market can be divided into Immunology, Hematology, Infectious Disease, Others include (Neurology, Cell & Gene Therapies, etc. Based on Techniques, the market is divided into Density Gradient Centrifugation, Leukapheresis, Others (Fluorescence Activated Cell Sorting, Magnetic-Activated Cell Sorting, etc. In terms of Source, the market can be categorized into Human and Animals.  

Company Profiles

Charles River Laboratories International, Inc., Lonza Group AG, Corning Inc, Bio-Rad Laboratories Inc, Biolegend Inc., ABCAM, ZEN-Bio Inc., DAPCEL, Inc., Creative Bioarray, iXCells Biotechnologies USA, LLC, Miltenyi Biotec B.V. & CO. KG, STEMCELL Technologies Inc., Precision Medicine Group, LLC., StemExpress, LLC, RayBiotech Life, Inc., REPROCELL Inc., Cytologics LLC, BioIVT LLC, Biopredic International and Cell Applications, Inc. are among the major market players in the global Peripheral Blood Mononuclear Cells market.

Attribute

Details

Market size value in FY2021

USD 216.52 Million

Revenue Forecast in FY2027

USD 365.80 Million

Growth Rate

9.38%

Base Year

2021

Historical Years

2017 – 2027

Estimated Year

2022

Forecast Period

2021 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

Product

Application

Technique

Source

Regional Scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Key Companies Profiled

Charles River Laboratories International, Inc., Lonza Group AG, Corning Inc, Bio-Rad Laboratories Inc, Biolegend Inc., ABCAM, ZEN-Bio Inc., DAPCEL, Inc., Creative Bioarray, iXCells Biotechnologies USA, LLC, Miltenyi Biotec B.V. & CO. KG, STEMCELL Technologies Inc., Precision Medicine Group, LLC., StemExpress, LLC, RayBiotech Life, Inc., REPROCELL Inc., Cytologics LLC, BioIVT LLC, Biopredic International and Cell Applications, Inc.

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/pdf format on special request)

 Report Scope:

In this report, Global Peripheral Blood Mononuclear Cells Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Peripheral Blood Mononuclear Cells Market, By Product:
    • Cryopreserved or Frozen PBMC
    • Cultured or Fresh PBMC
    • Peripheral Blood Mononuclear Cell Isolation & Viability Kits
  • Peripheral Blood Mononuclear Cells Market, By Application:
    • Immunology
    • Hematology
    • Infectious Disease
    • Others
  • Peripheral Blood Mononuclear Cells Market, By Techniques:
    • Density Gradient Centrifugation
    • Leukapheresis
    • Others
  • Peripheral Blood Mononuclear Cells Market, By Source:
    • Human
    • Animal
  • Peripheral Blood Mononuclear Cells Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Singapore
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • UAE
      • Saudi Arabia
      • South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Peripheral Blood Mononuclear Cells market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Impact of COVID-19 on Global Peripheral Blood Mononuclear Cells Market

5.    Voice of Customer

5.1.  By Type of Product

5.2.  By Type of Technique

5.3.  Type of Application for Which PBMCs Are Used

5.4.  Factors Driving Market Growth

6.    Global Peripheral Blood Mononuclear Cells Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC and Peripheral Blood Mononuclear Cell Isolation & Viability Kits)

6.2.2.     By Application (Immunology, Infectious Disease, Hematology and Others)

6.2.3.     By Technique (Density Gradient Centrifugation Process and Leukapheresis)

6.2.4.     By Source (Human and Animals)

6.2.5.     By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)

6.2.6.     By Company (2021)

6.3.  Market Map

6.3.1.     By Product

6.3.2.     By Application

6.3.3.     By Technique

6.3.4.     By Source

6.3.5.     By Region

7.    North America Peripheral Blood Mononuclear Cells Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product

7.2.2.     By Application

7.2.3.     By Technique

7.2.4.     By Source

7.2.5.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Peripheral Blood Mononuclear Cells Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Product

7.3.1.2.2.             By Application

7.3.1.2.3.             By Technique

7.3.1.2.4.             By Source

7.3.2.     Canada Peripheral Blood Mononuclear Cells Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Product

7.3.2.2.2.             By Application

7.3.2.2.3.             By Technique

7.3.2.2.4.             By Source

7.3.3.     Mexico Peripheral Blood Mononuclear Cells Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Product

7.3.3.2.2.             By Application

7.3.3.2.3.             By Technique

7.3.3.2.4.             By Source

8.    Europe Peripheral Blood Mononuclear Cells Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product

8.2.2.     By Application

8.2.3.     By Technique

8.2.4.     By Source

8.2.5.     By Country

8.3.  Europe: Country Analysis

8.3.1.     Germany Peripheral Blood Mononuclear Cells Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Product

8.3.1.2.2.             By Application

8.3.1.2.3.             By Technique

8.3.1.2.4.             By Source

8.3.2.     France Peripheral Blood Mononuclear Cells Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Product

8.3.2.2.2.             By Application

8.3.2.2.3.             By Technique

8.3.2.2.4.             By Source

8.3.3.     United Kingdom Peripheral Blood Mononuclear Cells Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Product

8.3.3.2.2.             By Application

8.3.3.2.3.             By Technique

8.3.3.2.4.             By Source

8.3.4.     Italy Peripheral Blood Mononuclear Cells Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Product

8.3.4.2.2.             By Application

8.3.4.2.3.             By Technique

8.3.4.2.4.             By Source

8.3.5.     Spain Peripheral Blood Mononuclear Cells Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Product

8.3.5.2.2.             By Application

8.3.5.2.3.             By Technique

8.3.5.2.4.             By Source

9.    Asia-Pacific Peripheral Blood Mononuclear Cells Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Product

9.2.2.     By Application

9.2.3.     By Technique

9.2.4.     By Source

9.2.5.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Peripheral Blood Mononuclear Cells Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Product

9.3.1.2.2.             By Application

9.3.1.2.3.             By Technique

9.3.1.2.4.             By Source

9.3.2.     Japan Peripheral Blood Mononuclear Cells Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Product

9.3.2.2.2.             By Application

9.3.2.2.3.             By Technique

9.3.2.2.4.             By Source

9.3.3.     India Peripheral Blood Mononuclear Cells Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Product

9.3.3.2.2.             By Application

9.3.3.2.3.             By Technique

9.3.3.2.4.             By Source

9.3.4.     South Korea Peripheral Blood Mononuclear Cells Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Product

9.3.4.2.2.             By Application

9.3.4.2.3.             By Technique

9.3.4.2.4.